Jay R. Luly

ENANTA PHARMACEUTICALS

President and Chief Executive Officer

Overview

Jay R. Luly received an average compensation of $2,670,229 at ENANTA PHARMACEUTICALS from 2011 to 2018.

Annual data

2018

Non-Equity Incentive Plan$355,688
Option Awards$2,684,490
Salary$611,178
Stock Awards$838,530
Other$18,851
Total$4,508,737

In 2018, Jay R. Luly earned a total compensation of $4,508,737 as President and Chief Executive Officer at ENANTA PHARMACEUTICALS INC.

Luly received $2,684,490 in option awards, which accounts for 59.54% of total compensation.

Luly also received $355,688 in non-equity incentive plan, $611,178 in salary, $838,530 in stock awards and $18,851 in other compensation.